Top-News
Pharmazeutika USA

Sutro Biopharma News

Aktie
WKN:  A2N6SG ISIN:  US8693671021 US-Symbol:  STRO
3,64 €
+0,06 €
+1,68%
17.05.24 21:59:37
Handeln Depot/Watchlist
Aktienanzahl *
60,95 Mio.
Marktkapitalisierung *
224,87 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 04.12.2023

Sutro Biopharma News

11.07.22 - PR Newswire
Thinking about buying stock in La Jolla Pharmaceutical, Toughbuilt Industries, Waitr Holdings, Sutro Biopharma, or Magnachip Semiconductor?
Thinking about buying stock in La Jolla Pharmaceutical, Toughbuilt Industries, Waitr Holdings, Sutro Biopharma, or Magnachip Semiconductor? PR Newswire
28.06.22 - PR Newswire
Thinking about buying stock in Kezar Life Sciences, Evofem Biosciences, Agile Therapeutics, Sutro Biopharma, or Wejo Group?
Thinking about buying stock in Kezar Life Sciences, Evofem Biosciences, Agile Therapeutics, Sutro Biopharma, or Wejo Group? PR Newswire
27.06.22 - PR Newswire
Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)
Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-​Drug Conjugates (iADCs) PR Newswire
29.04.22 - PR Newswire
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
08.04.22 - PR Newswire
Sutro Biopharma Presents Nonclinical Data for Antibody-Drug Conjugate STRO-002 at the AACR Annual Meeting 2022
Sutro Biopharma Presents Nonclinical Data for Antibody-​Drug Conjugate STRO-002 at the AACR Annual Meeting 2022 PR Newswire
05.04.22 - PR Newswire
Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference
Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference PR Newswire
30.03.22 - PR Newswire
Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugate Modality at the 12th Annual World ADC
Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-​Drug Conjugate Modality at the 12th Annual World ADC PR Newswire
03.03.22 - PR Newswire
Sutro Biopharma to Participate in the Cowen 42nd Annual Healthcare Conference
Sutro Biopharma to Participate in the Cowen 42nd Annual Healthcare Conference PR Newswire
28.02.22 - PR Newswire
Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones
Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones - Promising STRO-002 initial data on Phase 1 dose-​expansion ...
27.01.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sutro Biopharma, Inc. - STRO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sutro Biopharma, Inc. - STRO PR Newswire
17.01.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sutro Biopharma, Inc. - STRO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sutro Biopharma, Inc. - STRO PR Newswire
27.12.21 - PR Newswire
Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China
Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China - Tasly obtains exclusive development and ...
22.11.21 - PR Newswire
Sutro Biopharma to Participate in Two Upcoming Investor Conferences
Sutro Biopharma to Participate in Two Upcoming Investor Conferences PR Newswire
17.11.21 - PR Newswire
Sutro Biopharma Announces Appointment of Heidi Hunter to Board of Directors
Sutro Biopharma Announces Appointment of Heidi Hunter to Board of Directors - Heidi Hunter, accomplished healthcare leader and President of Cardinal Health Specialty ...
02.11.21 - PR Newswire
Sutro Biopharma to Participate in Three Upcoming Investor Conferences
Sutro Biopharma to Participate in Three Upcoming Investor Conferences PR Newswire
12.10.21 - PR Newswire
Sutro Biopharma and BioNova Pharmaceuticals Enter into Collaboration for STRO-001 in Greater China
Sutro Biopharma and BioNova Pharmaceuticals Enter into Collaboration for STRO-001 in Greater China PR Newswire
30.09.21 - PR Newswire
Sutro Biopharma Announces Extension of Cytokine Derivative Research Program Under Collaboration with Merck
Sutro Biopharma Announces Extension of Cytokine Derivative Research Program Under Collaboration with Merck PR Newswire
17.09.21 - PR Newswire
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
01.09.21 - PR Newswire
Sutro Biopharma to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
Sutro Biopharma to Participate in the 2021 Wells Fargo Virtual Healthcare Conference PR Newswire
18.08.21 - PR Newswire
Sutro Biopharma Announces STRO-002 FDA Fast Track Designation for Patients with Advanced Ovarian Cancer
Sutro Biopharma Announces STRO-002 FDA Fast Track Designation for Patients with Advanced Ovarian Cancer PR Newswire

Newssuche

Videos

newspaper
17.05.24 +14,15%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »